Wednesday, December 3, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Synchrony Financial Discloses 18 Million Charges FDIC Assessment and Restructuring Costs

Elaine Mendonca by Elaine Mendonca
January 23, 2024
in Breaking News
0
OHI stock news
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

On January 23, 2024, Synchrony Financial found itself burdened with a hefty $9 million charge from the FDIC, along with an additional $9 million in restructuring costs linked to their site strategy. The FDIC special assessment, a fee enforced by the Federal Deposit Insurance Corporation, was levied upon financial institutions to ensure the preservation of the Deposit Insurance Fund. As for the restructuring costs, they represented the expenses incurred due to significant alterations in Synchrony Financial’s operations and structure. These charges were openly disclosed by the company in its quarterly report to the U.S. Securities and Exchange Commission. It is important to note that the FDIC special assessment is a regulatory fee, while restructuring costs are typically one-time expenditures associated with organizational changes.

Synchrony Financial (SYF) Displays Strong Stock Performance and Positive Momentum on January 23, 2024

On January 23, 2024, Synchrony Financial (SYF) showcased a strong performance in the stock market. Trading near the top of its 52-week range and above its 200-day simple moving average, SYF displayed positive price momentum.

SYF shares experienced a notable increase of $0.86 since the market closed prior to January 23. This rise represents a 2.33% increase in the stock’s value. With a closing price of $37.77, investors witnessed a promising uptick in SYF’s performance.

However, it is worth noting that SYF faced a slight setback in pre-market trading, as the stock dropped $0.42. This decline indicates a minor fluctuation in the stock’s value before regular trading hours commenced.

Synchrony Financial, a leading consumer financial services company, has been a prominent player in the market. With a diverse range of products and services, including credit cards, installment loans, and savings products, SYF has gained the attention of investors.

Furthermore, being above its 200-day simple moving average indicates a sustained positive trend in SYF’s stock performance. This moving average is a widely used technical indicator that helps investors identify the stock’s overall direction. In this case, the fact that SYF is trading above its 200-day moving average is a positive sign for investors.

However, the slight drop of $0.42 in pre-market trading should not be cause for alarm. Pre-market trading is often characterized by lower trading volumes and increased price volatility. Fluctuations during this period may not accurately reflect the stock’s overall performance throughout the trading day.

In conclusion, Synchrony Financial’s stock performance on January 23, 2024, demonstrated positive momentum. Trading near the top of its 52-week range and above its 200-day simple moving average, SYF showcased strength in the market. While a slight drop was observed in pre-market trading, this should not overshadow the overall positive sentiment surrounding the company. Investors continue to have confidence in Synchrony Financial’s ability to deliver strong financial results in the future.

SYF Stock Performance: Mixed Indicators with Revenue Growth but Decline in Net Income and EPS

SYF stock, the ticker symbol for Synchrony Financial, had a mixed performance on January 23, 2024, based on the provided information from CNN Money. The company’s total revenue for the past year was $13.20 billion, which represents a 17.56% increase compared to the previous year. Additionally, the total revenue for the most recent quarter, Q3, was $4.47 billion, indicating a 6.48% increase since the previous quarter.

The net income for the past year was $3.02 billion, reflecting a 28.55% decrease compared to the previous year. Despite this decline, the net income for the most recent quarter, Q3, was $628.00 million, showing a 10.37% increase since the previous quarter.

The earnings per share (EPS) for the past year were $6.15, representing a 16.19% decrease compared to the previous year. On the other hand, the EPS for the most recent quarter, Q3, was $1.48, indicating a 12.09% increase since the previous quarter.

Overall, Synchrony Financial’s stock performance on January 23, 2024, was a mix of positive and negative indicators. The company experienced significant revenue growth over the past year, indicating a strong demand for its products and services. However, the decrease in net income and EPS over the past year raises concerns about the company’s profitability. Nevertheless, the recent increase in net income and EPS suggests that Synchrony Financial is taking steps to address these concerns and improve its financial performance. Investors should closely monitor the company’s future financial results to assess its long-term prospects.

Tags: SYF
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Pharmaceutical Markets and money

4D Molecular Therapeutics Receives Rare Pediatric Disease Designation for Groundbreaking Cystic Fibrosis Treatment

DVY stock news

Uncertain Future and Potential Investment Opportunities in the Global Lithium Market

Technology Data analytics stock Trading

Analyst at Wedbush Reaffirms Neutral Rating on Logitech International with 90 Price Target

Recommended

Karyopharm Therapeutics Stock

Karyopharm Therapeutics: Surging Shares Mask Growing Technical Concerns

3 months ago
Sterling Stock

Sterling Infrastructure Stock Surges on Strong Fundamentals and Strategic Vision

3 months ago
Cue Biopharma Stock

Cue Biopharma: A High-Stakes Investment With 400% Upside Potential

3 months ago
FAT Brands Stock

FAT Brands Stock: Navigating a Critical Juncture

3 weeks ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Horizon Bancorp Stock: Analysts Project Double-Digit Gains Amid Rate Uncertainty

MP Materials Stock Gains on Strategic Positioning and Institutional Backing

Mercantile Bank Shares: Poised for a Significant Breakout?

Figma’s Stock Plunge: A Battle for Investor Confidence

Broadcom Stock: Analysts Boost Targets Ahead of Critical Earnings

Viking Therapeutics Stock: Key Milestone Accelerates Timeline

Trending

Quantum eMotion Stock
AI & Quantum Computing

Quantum eMotion Stock Gains on Dual Commercial Deals

by Andreas Sommer
December 3, 2025
0

A significant shift is underway for Quantum eMotion (TSXV: QNC). The company has announced two major strategic...

Hims & Hers Stock

Hims & Hers Shares Face Sustained Selling Pressure

December 3, 2025
Healwell AI Stock

Healwell AI Shares Plunge Despite Record Financial Performance

December 3, 2025
Horizon Stock

Horizon Bancorp Stock: Analysts Project Double-Digit Gains Amid Rate Uncertainty

December 3, 2025
MP Materials Stock

MP Materials Stock Gains on Strategic Positioning and Institutional Backing

December 3, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Quantum eMotion Stock Gains on Dual Commercial Deals
  • Hims & Hers Shares Face Sustained Selling Pressure
  • Healwell AI Shares Plunge Despite Record Financial Performance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com